When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

In this thesis, we have investigated a specific type of T cell, the γδT cell, and its potential as an immunotherapy against cancer. We aimed to improve current γδT cell-based therapies and demonstrate ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...